Equities Analysts Issue Forecasts for Quantum-Si Q1 Earnings

Quantum-Si Incorporated (NASDAQ:QSI) – Equities research analysts at HC Wainwright issued their Q1 2026 earnings per share estimates for shares of Quantum-Si in a research note issued on Friday, March 6th. HC Wainwright analyst S. Ramakanth anticipates that the company will earn ($0.12) per share for the quarter. The consensus estimate for Quantum-Si’s current full-year earnings is ($0.65) per share. HC Wainwright also issued estimates for Quantum-Si’s Q2 2026 earnings at ($0.12) EPS, Q3 2026 earnings at ($0.13) EPS, Q4 2026 earnings at ($0.13) EPS and FY2030 earnings at $0.00 EPS.

Quantum-Si (NASDAQ:QSI) last released its earnings results on Tuesday, March 3rd. The company reported ($0.08) EPS for the quarter, topping analysts’ consensus estimates of ($0.14) by $0.06. The firm had revenue of $0.45 million for the quarter, compared to analysts’ expectations of $0.76 million. Quantum-Si had a negative return on equity of 43.90% and a negative net margin of 4,160.06%.

Other equities analysts have also issued reports about the stock. Canaccord Genuity Group decreased their price objective on shares of Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a report on Wednesday, March 4th. Weiss Ratings reissued a “sell (d-)” rating on shares of Quantum-Si in a report on Monday, December 29th. Two investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $3.25.

Quantum-Si Stock Performance

NASDAQ:QSI opened at $0.93 on Monday. The firm has a 50-day simple moving average of $1.09 and a two-hundred day simple moving average of $1.37. The firm has a market cap of $199.52 million, a P/E ratio of -1.78 and a beta of 3.00. Quantum-Si has a fifty-two week low of $0.84 and a fifty-two week high of $3.10.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the company. Prudential Financial Inc. purchased a new stake in shares of Quantum-Si during the 2nd quarter valued at about $25,000. Curbstone Financial Management Corp purchased a new stake in Quantum-Si during the fourth quarter valued at approximately $26,000. Capital Investment Advisory Services LLC boosted its stake in shares of Quantum-Si by 100.0% during the 3rd quarter. Capital Investment Advisory Services LLC now owns 20,000 shares of the company’s stock worth $28,000 after acquiring an additional 10,000 shares during the last quarter. Leonteq Securities AG bought a new stake in shares of Quantum-Si during the 4th quarter valued at $28,000. Finally, Elite Life Management LLC purchased a new stake in shares of Quantum-Si in the 3rd quarter worth $29,000. Institutional investors own 39.90% of the company’s stock.

Insider Activity at Quantum-Si

In other Quantum-Si news, CEO Jeffrey Alan Hawkins sold 23,707 shares of Quantum-Si stock in a transaction that occurred on Monday, December 22nd. The shares were sold at an average price of $1.28, for a total value of $30,344.96. Following the completion of the sale, the chief executive officer owned 2,578,018 shares of the company’s stock, valued at approximately $3,299,863.04. The trade was a 0.91% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Paula Dowdy purchased 109,890 shares of the company’s stock in a transaction dated Thursday, March 5th. The stock was purchased at an average price of $0.95 per share, for a total transaction of $104,395.50. Following the completion of the purchase, the director owned 269,107 shares in the company, valued at approximately $255,651.65. The trade was a 69.02% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders sold 54,261 shares of company stock valued at $69,454 over the last ninety days. Company insiders own 22.95% of the company’s stock.

About Quantum-Si

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.